Peter Rock is currently Chief Finance Officer at Alloy Therapeutics LLC, and Etiometry Inc., a predictive analytics company in healthcare. He has raised over $16M in debt and equity financings for Etiometry. Mr. Rock has 28+ years of financial management and operations experience with a variety of large industrial companies (United Technologies, AEG Schneider Automation and Avery Dennison) and the last 20 years focused on life science and early stage tech companies.
Bachelors of Business Administration, University of Massachusetts – Amherst
Master of Business Administration, Rensselaer Polytechnic Institute
He was VP of Finance and Administartion for Dyax Corp managing the finance and operational functions leading to their successful IPO in 2000. In 2002 Mr. Rock began his career as a contract CFO for early stage technology and life science companies. He has helped raise over $40 million in private financings and successfully sold 3 businesses for his clients.
He has served as Chairman of Massachusetts Biotechnology Council’s finance committee and served on and chaired the Business Solutions Advisory Board for the Biotechnology Industry Organization (BIO). Mr. Rock received a BBA from University of Massachusetts – Amherst and an MBA from Rensselaer Polytechnic Institute.